Nicholas E Hagemeier
Overview
Explore the profile of Nicholas E Hagemeier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salwan A, Mathis S, Brooks B, Hagemeier N, Tudiver F, Foster K, et al.
Res Social Adm Pharm
. 2024 Jul;
20(10):978-985.
PMID: 38981793
Background: Increasing access to naloxone reduces opioid-related morbidity and mortality. Primary care and community pharmacy settings are critical access points, yet limited theoretical research has examined naloxone prescribing and dispensing...
2.
Mitchell H, King S, Ginley M, Foster K, Hagemeier N, Sevak R
J Am Coll Health
. 2023 Mar;
72(9):3556-3563.
PMID: 36862548
The present study identified common motives for nonmedical use of prescription stimulants (NMUS) among community college (CC) students and examined behavioral and demographic correlates of certain motives. The survey was...
3.
Dilliard R, Hagemeier N, Ratliff B, Maloney R
Explor Res Clin Soc Pharm
. 2022 Apr;
2:100042.
PMID: 35481120
Background: Lay press investigations have been published that describe pharmacist errors and the workplace environment in the community pharmacy setting. However, recent studies that explore pharmacists' perceptions of patient safety...
4.
Melton T, Hagemeier N, Tudiver F, Foster K, Arnold J, Brooks B, et al.
J Opioid Manag
. 2022 Mar;
18(1):75-83.
PMID: 35238016
Objective: Primary care physicians (PCPs) are positioned to mitigate opioid morbidity and mortality, but their engagement in primary, secondary, and tertiary opioid-related prevention behaviors is unclear. The objective of this...
5.
Hagemeier N, Dowling-McClay K
Am J Pharm Educ
. 2021 Jul;
85(4):8291.
PMID: 34283792
To characterize the impact of COVID-19 transitions on first professional year (P1) students' domain-specific and overall well-being. All P1 students (N=74) enrolled at one college of pharmacy self-reported their career,...
6.
Hagemeier N, Dowling-McClay K, Baladezaei M, Curtis S, Spence M
Drug Alcohol Depend
. 2021 Feb;
221:108597.
PMID: 33631542
Background: One approach to increasing the reach of syringe programs in rural areas could be through provision of syringes at community pharmacies. This study evaluated relationships between state-specific syringe policies,...
7.
Hagemeier N, Carlson T, Roberts C, Thomas M
Am J Pharm Educ
. 2020 Aug;
84(7):ajpe7735.
PMID: 32773830
To assess and characterize Doctor of Pharmacy (PharmD) students' well-being across the first professional year (P1) and determine the relationship between the number of examinations taken, student grade point average,...
8.
Salwan A, Hagemeier N, Tudiver F, Dowling-McClay K, Foster K, Arnold J, et al.
J Am Pharm Assoc (2003)
. 2020 Jul;
60(6):e173-e178.
PMID: 32669219
Objectives: This study describes community pharmacists' opioid analgesic and medication for opioid use disorder (MOUD) practice behaviors and behavioral intentions in the context of primary, secondary, and tertiary prevention of...
9.
Gregory D, Boje K, Carter R, Daugherty K, Hagemeier N, Munger M, et al.
Am J Pharm Educ
. 2020 Feb;
83(10):7661.
PMID: 32001895
The Committee was charged with the responsibility for examining the need for change in pharmacy education and the models of leadership that would enable that change to occur across the...
10.
Ventricelli D, Mathis S, Foster K, Pack R, Tudiver F, Hagemeier N
Subst Use Misuse
. 2019 Oct;
55(3):349-357.
PMID: 31591924
Patients engaged in evidence-based opioid use disorder (OUD) treatment can obtain prescriptions for buprenorphine containing products from specially trained physicians that are subsequently dispensed by community pharmacists. Despite the involvement...